Araoz & Rueda, with a team led by partner Alejandro Fernández de Araoz and associate Vicente Paramio, has advised the German pharmaceutical company Dermapharm, listed on the German Stock Exchange, on the acquisition of Euromed Botanicals, a Barcelona-based company specializing in the manufacture of herbal extracts and natural active substances.
The transaction is part of the growth plan of the German multinational to strengthen its international expansion, taking advantage of the knowledge of Euromed of the Spanish market.
Euromed, advised on the legal side by Allen & Overy and EY, was owned by US global private equity firm Riverside. The Catalan group, which operates in 35 countries around the world, expects to reach a turnover of € 67 million in 2018 and an EBITDAaround € 18 million (70 million and 20 million, respectively, is expected in 2019)
The financial advice of the transaction has been provided by Rothschild, Fidentiis and Ferber & Co.